Resilience raises $45 million for its cancer care startup – TechCrunch
french startup Resilience announced yesterday that it has raised a $45 million (€40 million) Series A funding round led by Cathay Innovation. The startup wants to improve the treatment journey when you are diagnosed with cancer so that you live longer and healthier.
In addition to Cathay Innovation, existing investor Singular is also participating. Other funds are joining the round, such as Exor Seeds, Picus Capital and Seaya Ventures. Finally, some health investors complete the round – Fondation Santé Service, MACSF, Ramsay Santé and Vivalto Ventures.
I already profiled Resilience in March 2021 so I encourage you to read my previous article to learn more about the company. Co-founded by two serial entrepreneurs, Céline Lazorthes and Jonathan Benhamou, the company aims to help both patients and caregivers in the management of cancer.
On the patient side, Resilience helps you measure, understand and treat the effects and side effects of cancer and cancer treatments. Users can track various data points in the app and find content and information about their disease.
But Resilience isn’t just an app you use at home. It is also a software-as-a-service solution for hospitals so they can better personalize their treatments. Resilience was founded in partnership with Gustave Roussy, one of the world’s leading cancer research institutes.
Practitioners will be able to take advantage of all the data patients have collected from the app. This way, cancer treatment facilities understand the patient better and can adapt their care more quickly. Resilience has acquired To improve get a head start in data-driven cancer care.
The long-term vision is even more ambitious than that. If you speak with a caregiver working for a cancer treatment center, they will tell you that there is never enough time.
And it is even more difficult to keep up with the new, increasingly specialized treatments. Resilience does not want to replace doctors. But he wants to help them overcome blind spots.
The result should be better patient care, as well as increased support through the Resilience app. Cancer care is a long and painful process, so anything that can improve that process is a good thing.